Daphnetin protects oxidative stress-induced neuronal apoptosis via regulation of MAPK signaling and HSP70 expression

Zhilin Qi, Shimei Qi, Lin Gui, Lei Shen, Zunyong FengOncology 2016 · DOI

Abstract

Neurodegenerative disorders are characterized by the progressive loss of neurons, often driven by oxidative stress. This study investigates the neuroprotective effects of Daphnetin, a natural compound from Changbai daphne, using neuronal-like PC12 cells. We found that Daphnetin significantly attenuates hydrogen peroxide ($H_2O_2$)-induced apoptosis in a concentration-dependent manner. Mechanistically, Daphnetin modulates the Mitogen-Activated Protein Kinase (MAPK) signaling rheostat by inhibiting pro-apoptotic p38 and JNK pathways while activating the pro-survival ERK1/2 pathway. This activation of ERK leads to the induction of Heat Shock Protein 70 (HSP70), a molecular chaperone that shields cells from damage. These findings suggest that Daphnetin is a potential therapeutic candidate for treating neurodegenerative diseases.

Introduction

Neurodegenerative diseases such as Alzheimer’s and Parkinson’s involve the gradual degeneration of neurons, a process heavily linked to oxidative stress. Reactive oxygen species (ROS), including hydrogen peroxide ($H_2O_2$), trigger programmed cell death (apoptosis) in the brain. Identifying natural antioxidants that can mitigate this damage is a key area of research due to their typically low toxicity.

Daphnetin (7,8-dihydroxycoumarin) has previously demonstrated anti-inflammatory and anti-tumor properties. However, its role in neuroprotection and the specific molecular pathways it manipulates remained unclear. This study aims to elucidate how Daphnetin protects neuronal cells from oxidative injury.

Methods

The researchers utilized PC12 cells (rat pheochromocytoma cells) as a model for neurons. The experimental design followed a "challenge and rescue" protocol:

  1. Oxidative Stress Induction: Cells were exposed to $H_2O_2$ to simulate oxidative damage.
  2. Pretreatment: Cells were treated with Daphnetin (2.5 to 20 µM) for 2 hours before the $H_2O_2$ challenge.
  3. Viability & Apoptosis Assays: Cell survival was measured using CCK-8 assays, and apoptosis was quantified via Annexin V-FITC/PI flow cytometry.
  4. Morphological Analysis: Inverted and fluorescence microscopy (with DAPI staining) visualized physical changes like nuclear fragmentation.
  5. Molecular Signaling: Western blotting measured the activation of MAPKs (p38, JNK, and ERK) and the expression of HSP70.
  6. Pathway Verification: The ERK inhibitor U0126 was used to confirm the link between ERK activation and HSP70 expression.

Results

Daphnetin Rescues Cell Viability

Exposure to $H_2O_2$ significantly reduced PC12 cell viability in a dose-dependent manner. As shown in Figure 1A, viability dropped significantly as $H_2O_2$ concentrations increased. However, pretreatment with Daphnetin (DAP) provided a robust rescue effect. In cells challenged with 200 µM $H_2O_2$, which reduced viability to approximately 48%, treatment with 20 µM DAP restored viability to nearly 78% (Figure 1B).

Daphnetin increases cell viability in $H_2O_2$-treated PC12 cells.

Morphological Preservation and Safety

Fluorescence microscopy using DAPI staining confirmed that Daphnetin at the highest experimental dose (20 µM) did not induce nuclear fragmentation or apoptosis on its own, indicating its safety profile in this model (Figure 1D).

Nuclear morphology of PC12 cells treated with Daphnetin.

Modulation of MAPK and HSP70

The study revealed that Daphnetin acts as a dual-regulator of the MAPK signaling network. It inhibited the phosphorylation of p38 and JNK (the "death signals") while simultaneously boosting the phosphorylation of ERK (the "survival signal"). This ERK activation was directly responsible for the induction of HSP70, which peaked 12 hours after treatment. When the ERK pathway was blocked with the inhibitor U0126, the protective increase in HSP70 was abolished, confirming the ERK-HSP70 axis as a primary mechanism of neuroprotection.

Discussion

Daphnetin protects neurons by fine-tuning the cellular response to stress. By suppressing pro-apoptotic pathways and activating a pro-survival chaperone response through the ERK/HSP70 axis, it effectively shields cells from oxidative-induced death.

While these results are promising, the study is limited to an in vitro model. Future research must determine if Daphnetin can cross the blood-brain barrier and validate these effects in animal models of neurodegeneration. Nevertheless, Daphnetin represents a compelling natural candidate for further development in the treatment of diseases characterized by oxidative neuronal loss.

Summary updated

Abstract

Neurodegenerative disorders are characterized by progressive degeneration and loss of neurons in the brain. Oxidative stress is implicated in the pathogenesis of neurological disorders, although the pathological mechanism remains unelucidated. Daphnetin, an active ingredient extracted from <i>Changbai daphne</i> (Daphne Korean Nakai), exhibits various pharmacological effects, including anti-inflammatory, anti-oxidative and anti-tumor effects. However, the neuroprotective effects, as well as the specific mechanisms of daphnetin, remain unclear. Neuronal-like rat pheochromocytoma PC12 cells were pretreated with daphnetin for 2 h, then treated with or without H<sub>2</sub>O<sub>2</sub> for various times. Cell morphology was detected using an inverted microscope, the apoptotic ratio was determined by Annexin V fluorescein isothiocyanate/propidium iodide assay, nuclear morphology was observed and photographed using a fluorescence microscope following 4',6-diamidino-2-phenylindole staining. The levels of pro-caspase 3, cleavage of poly ADP-ribose polymerase and caspase 3 were detected by western blotting. In addition, the activation of mitogen-activated protein kinase (MAPK) signal pathway and the expression of HSP70 were detected by western blotting. The present study demonstrated that daphnetin attenuated hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced apoptosis in a concentration-dependent manner, reduced the cleavage of poly ADP ribose polymerase and caspase 3, and inhibited the phosphorylation of p38 MAPK and c-Jun N-terminal kinases (JNK) in H<sub>2</sub>O<sub>2</sub>-induced PC12 cells. In addition, daphnetin induced the expression of HSP70 in a dose- and time-dependent manner, and daphnetin-induced HSP70 expression was reduced by extracellular signal-regulated kinase (ERK) 1/2 inhibitor U0126 in PC12 cells. Therefore, the present results indicate that daphnetin protects PC12 cells against oxidative stress injury by regulating p38 MAPK and JNK signaling and increasing the expression of HSP70 via ERK signaling. This suggests that daphnetin may have the potential to treat certain neurodegenerative diseases. The present results not only provide insight into the potential use of daphnetin in H<sub>2</sub>O<sub>2</sub>-induced PC12 cell apoptosis, but also highlight the potential role of HSP70 in neuroprotection.
BibTeX
@inproceedings{qi2016daphnetin,
  author = {Zhilin Qi and Shimei Qi and Lin Gui and Lei Shen and Zunyong Feng},
  title = {{Daphnetin protects oxidative stress-induced neuronal apoptosis via regulation of MAPK signaling and HSP70 expression}},
  booktitle = {Oncology},
  year = {2016},
  doi = {10.3892/ol.2016.4849},
}
Figure